Physician

Aaron Lynn Luebke, MD

According to 2025 Medicare claims, Aaron Luebke, MD (NPI: 1699929281) practices hematology/oncology in the Bismarck, ND market, with the plurality of this provider's patient population coming from Burleigh, ND. This provider's primary affiliated billing organization is SANFORD BISMARCK (NPI: 1811941172; TIN: 450226700) and primary practice location at 58501-4457. Luebke is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), The Rural Advantage LLC (ACO ID: A5257), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Luebke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 674 traditional Medicare patients, billed 1,729 HCPCS/CPT codes, and received $112,996 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,168 prescription claims across 346 beneficiaries totaling $4,550,602 in drug costs, led by Ojjaara (Momelotinib Dihydrochloride). DME data shows 215 claims. Open Payments data shows 8 records totaling $251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $2,453,538 to $112,996. In contrast, Part D prescription costs have moved sharply higher in recent years, from $1,735,146 to $4,550,602. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $14,088 and ending at $7,560.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	492	257,743	$2,453,538
2016	494	195,391	$2,122,348
2017	633	206,270	$3,015,128
2018	865	376,230	$4,392,970
2019	720	317,301	$4,859,476
2020	557	110,956	$1,794,614
2021	509	1,849	$131,295
2022	583	1,857	$125,157
2023	626	1,695	$108,957
2024	674	1,729	$112,996

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	1,399	$1,735,146
2016	240	1,549	$1,948,630
2017	278	1,608	$2,228,087
2018	318	1,918	$2,747,733
2019	309	1,834	$3,085,595
2020	279	1,243	$2,108,983
2021	257	1,378	$2,236,749
2022	266	1,653	$3,172,869
2023	307	1,983	$3,903,913
2024	346	2,168	$4,550,602

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	98	415	$19,612
2016	60	268	$9,526
2017	81	455	$25,915
2018	49	352	$19,655
2019	76	417	$16,851
2020	57	251	$12,179
2021	N/R	178	$9,920
2022	N/R	105	$2,890
2023	N/R	225	$29,609
2024	N/R	215	$5,971

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	54	54	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	29	33	$100
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	35	35	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	418	994	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	328	516	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ojjaara	Momelotinib Dihydrochloride	12	360	$683,203
Lenvima	Lenvatinib Mesylate	25	750	$606,817
Calquence	Acalabrutinib Maleate	34	1,020	$433,561
Erleada	Apalutamide	32	1,290	$432,501
Alecensa	Alectinib Hcl	21	630	$382,810

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	55	$1,627
J8700	Temozolomide, oral, 5 mg	N	N/R	21	$1,129
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	13	$968
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	50	$885
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	49	$784

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$251	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Lynn Luebke, MD?

Tedicare shows public-source Medicare data for Aaron Lynn Luebke, MD (NPI 1699929281), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Lynn Luebke, MD have ACO affiliation data?

Aaron Lynn Luebke, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), The Rural Advantage LLC (MSSP, ACO ID A5257), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Aaron Lynn Luebke, MD?

Aaron Lynn Luebke, MD is linked to SANFORD BISMARCK (billing NPI 1811941172) in the available physician profile data.

Does Aaron Lynn Luebke, MD have Open Payments data?

Aaron Lynn Luebke, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.